1. Home
  2. VTAK vs AKAN Comparison

VTAK vs AKAN Comparison

Compare VTAK & AKAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTAK
  • AKAN
  • Stock Information
  • Founded
  • VTAK 2002
  • AKAN 2021
  • Country
  • VTAK United States
  • AKAN Canada
  • Employees
  • VTAK N/A
  • AKAN N/A
  • Industry
  • VTAK Medical/Dental Instruments
  • AKAN Medicinal Chemicals and Botanical Products
  • Sector
  • VTAK Health Care
  • AKAN Health Care
  • Exchange
  • VTAK Nasdaq
  • AKAN Nasdaq
  • Market Cap
  • VTAK 3.1M
  • AKAN 2.9M
  • IPO Year
  • VTAK 2018
  • AKAN 2022
  • Fundamental
  • Price
  • VTAK $0.17
  • AKAN $1.05
  • Analyst Decision
  • VTAK
  • AKAN
  • Analyst Count
  • VTAK 0
  • AKAN 0
  • Target Price
  • VTAK N/A
  • AKAN N/A
  • AVG Volume (30 Days)
  • VTAK 1.9M
  • AKAN 59.1K
  • Earning Date
  • VTAK 08-13-2025
  • AKAN 08-05-2025
  • Dividend Yield
  • VTAK N/A
  • AKAN N/A
  • EPS Growth
  • VTAK N/A
  • AKAN N/A
  • EPS
  • VTAK N/A
  • AKAN N/A
  • Revenue
  • VTAK $481,000.00
  • AKAN $836,664.00
  • Revenue This Year
  • VTAK $822.86
  • AKAN N/A
  • Revenue Next Year
  • VTAK $168.42
  • AKAN N/A
  • P/E Ratio
  • VTAK N/A
  • AKAN N/A
  • Revenue Growth
  • VTAK 9.57
  • AKAN 97.47
  • 52 Week Low
  • VTAK $0.15
  • AKAN $0.93
  • 52 Week High
  • VTAK $2.49
  • AKAN $4.10
  • Technical
  • Relative Strength Index (RSI)
  • VTAK 31.31
  • AKAN 41.02
  • Support Level
  • VTAK $0.20
  • AKAN $1.10
  • Resistance Level
  • VTAK $0.24
  • AKAN $1.46
  • Average True Range (ATR)
  • VTAK 0.02
  • AKAN 0.11
  • MACD
  • VTAK -0.01
  • AKAN -0.01
  • Stochastic Oscillator
  • VTAK 4.13
  • AKAN 11.11

About VTAK Catheter Precision Inc.

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.

About AKAN Akanda Corp.

Akanda Corp is a cannabis cultivation, manufacturing, and distribution company. The company has three reportable segments: Cultivation, Distribution, and Corporate. A majority of its revenue is generated from the Distribution segment, which relates to the distribution of medical cannabis products, including cannabis oil and cannabis flower for medical use in the United Kingdom.

Share on Social Networks: